Osteopenia Completed Phase 2 Trials for Alendronic acid (DB00630)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004488Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's DiseaseTreatment